Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effects of combined exposure to two bisphenol plasticizers (BPA and BPB) on Xenopus laevis development.

Reproductive toxicology (Elmsford, N.Y.)·2024

Same author

Predicting estrogen receptor binding of chemicals using a suite of in silico methods - Complementary approaches of (Q)SAR, molecular docking and molecular dynamics.

Toxicology and applied pharmacology·2019

Same author

Identification of Metabolites of the Fungicide Penconazole in Human Urine.

Chemical research in toxicology·2016

Same author

A peptide topological template for the dispersion of [60]fullerene in water.

Organic & biomolecular chemistry·2014

Same author

Identification and quantification of metabolites of the fungicide tebuconazole in human urine.

Chemical research in toxicology·2014

Same author

Synthesis of luminescent 3D microstructures formed by carbon quantum dots and their self-assembly properties.

Chemical communications (Cambridge, England)·2014

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

Testing for organophosphate-induced delayed polyneuropathy.

¹Università degli Studi di Padova, Padova, Italy.

Current Protocols in Toxicology

|October 20, 2010

Summary

This summary is machine-generated.

Organophosphorus compounds cause acute cholinergic toxicity or delayed neuropathy. Hens are used to test for organophosphate-induced delayed polyneuropathy (OPIDP) by measuring enzyme activity in nervous tissues.

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Related Experiment Videos

Last Updated: Jun 7, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Area of Science:

Toxicology
Neuroscience
Biochemistry

Background:

Organophosphorus compounds (OPs) exhibit dual toxicity: acute cholinergic effects and organophosphate-induced delayed polyneuropathy (OPIDP).
Distinguishing between these toxicities is crucial for risk assessment and therapeutic development.
OPIDP is a significant concern due to its potential for severe, long-lasting neurological damage.

Purpose of the Study:

To describe and validate an assay for assessing the OPIDP-inducing potential of organophosphorus compounds.
To differentiate OPIDP from acute cholinergic toxicity using specific enzymatic markers.
To establish a method that can be incorporated into screening protocols for neuroprotective agents against OPIDP.

Main Methods:

The assay involves administering the test compound to hens, a validated animal model for OPIDP.
Post-administration, nervous tissues (brain, spinal cord, peripheral nerves) are analyzed.
Neuropathy target esterase (NTE) activity is measured to detect OPIDP, while acetylcholinesterase (AChE) activity is assessed to rule out acute toxicity.

Main Results:

The described hen assay effectively detects the neuropathic potential of organophosphorus compounds by monitoring NTE activity.
Simultaneous measurement of AChE activity allows for the exclusion of acute cholinergic toxicity, ensuring specificity.
The assay provides a reliable method for identifying compounds that induce OPIDP.

Conclusions:

The hen-based assay is a robust tool for evaluating organophosphate-induced delayed polyneuropathy.
This method facilitates the differentiation of OPIDP from acute cholinergic toxicity.
The assay serves as a valuable component in screening for agents that can protect against organophosphate-induced neurotoxicity.